Loading...
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. It was previously found that 5‐ASA drugs in doses of at least 2 g/day were more effective than placebo but no more effective than...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2020
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189994/ https://ncbi.nlm.nih.gov/pubmed/32786164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|